{"url_path":"/sec/sonm/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-024644-index.html","accession_number":"0001493152-26-024644","cik":"0001178697","ticker":"SONM","issuer_name":"DNA X, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1178697/0001493152-26-024644-index.html","primary_entity_key":"0001178697","primary_entity_name":"DNA X, Inc."},"word_count":42,"has_tables":true,"body_markdown":"**Item\n1. Legal Proceedings.**\n\n \n\nFor\ninformation regarding our material legal proceedings, see “Note 9 — Commitments and Contingencies” in the\naccompanying “Notes to Unaudited Condensed Consolidated Financial Statements” in this Quarterly Report on Form 10-Q,\nwhich information is incorporated herein by reference."}